Cardiff Oncology
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $120 | $121 | $109 | $151 |
Gross Profit | 120 | -11,459 | 109 | 151 |
EBITDA | -10,764 | -14,683 | -14,154 | -12,476 |
EBIT | -11,258 | -14,777 | -14,382 | -12,572 |
Net Income | -11,258 | -13,943 | -13,434 | -11,787 |
Net Change In Cash | 120 | 121 | 109 | 151 |
Free Cash Flow | -10,852 | -8,353 | -12,794 | -10,267 |
Cash | 10,135 | 10,784 | 24,095 | 51,470 |
Basic Shares | 66,879 | 66,526 | 47,650 | 47,650 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $683 | $488 | $386 | $359 |
Gross Profit | 683 | 488 | 386 | 359 |
EBITDA | -48,247 | -45,014 | -39,666 | -28,404 |
EBIT | -48,651 | -45,412 | -39,902 | -28,855 |
Net Income | -45,431 | -41,441 | -38,704 | -28,291 |
Net Change In Cash | 683 | 488 | 386 | 359 |
Cost of Revenue | 4,404 | -119,038 | ||
Free Cash Flow | -37,773 | -31,469 | -34,712 | -23,245 |
Cash | 51,470 | 21,655 | 16,347 | 11,943 |
Basic Shares | 47,650 | 44,677 | 43,600 | 39,030 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.17 |
2025-06-30 | -$0.21 |
2025-03-31 | -$0.20 |
